| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Novel Inducer of Autophagy in the Heart ∗
|
Mukai, Risa
|
|
|
6 |
4 |
p. 381-383
|
artikel
|
| 2 |
Conduits’ Biology Regulates the Outcomes of Coronary Artery Bypass Grafting
|
Gharibeh, Lara
|
|
|
6 |
4 |
p. 388-396
|
artikel
|
| 3 |
Decentralized Clinical Trials
|
Van Norman, Gail A.
|
|
|
6 |
4 |
p. 384-387
|
artikel
|
| 4 |
Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary Bypass
|
Salomon, Jeffrey
|
|
|
6 |
4 |
p. 311-327
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
6 |
4 |
p. A1-A3
|
artikel
|
| 6 |
Full Issue Pdf
|
|
|
|
6 |
4 |
p. I-XCV
|
artikel
|
| 7 |
FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In Vivo
|
Kuhn, Christian
|
|
|
6 |
4 |
p. 365-380
|
artikel
|
| 8 |
Injectable Biomaterials and Myocardial Infarction
|
Spinale, Francis G.
|
|
|
6 |
4 |
p. 362-364
|
artikel
|
| 9 |
Injectable Myocardial Matrix Hydrogel Mitigates Negative Left Ventricular Remodeling in a Chronic Myocardial Infarction Model
|
Diaz, Miranda D.
|
|
|
6 |
4 |
p. 350-361
|
artikel
|
| 10 |
Reply
|
Sharp, Thomas E.
|
|
|
6 |
4 |
p. 397-399
|
artikel
|
| 11 |
SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis
|
Bailey, Adam L.
|
|
|
6 |
4 |
p. 331-345
|
artikel
|
| 12 |
The Essential Vulnerability of Human Cardiac Myocytes to SARS-CoV-2 ∗
|
Das, Mitali
|
|
|
6 |
4 |
p. 346-349
|
artikel
|
| 13 |
The Microbiome is a Welcome Addition to the Growing “Omes” of Cardiopulmonary Bypass in Congenital Heart Disease Surgery ∗
|
Watson, John D.
|
|
|
6 |
4 |
p. 328-330
|
artikel
|
| 14 |
Tolerating Large Preclinical Models of HFpEF But Without the Intolerance?
|
Justo da Silva, Gustavo Jose
|
|
|
6 |
4 |
p. 397
|
artikel
|
| 15 |
Will Artificial Intelligence Transform Translational Medicine
|
Mann, Douglas L.
|
|
|
6 |
4 |
p. 400-401
|
artikel
|
Tijdschrift beschrijving